Cargando…

Animal Models of ANCA Associated Vasculitis

Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is a rare and severe autoimmune multisystemic disease. Its pathogenesis involves multiple arms of the immune system, as well as complex interactions between immune cells and target organs. Experimental animal models of disease c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shochet, Lani, Holdsworth, Stephen, Kitching, A. Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179669/ https://www.ncbi.nlm.nih.gov/pubmed/32373109 http://dx.doi.org/10.3389/fimmu.2020.00525

Ejemplares similares

Neutrophil Extracellular Traps: A Potential Therapeutic Target in MPO-ANCA Associated Vasculitis?
por: O'Sullivan, Kim M., et al.
Publicado: (2021)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
por: Wallace, Zachary S., et al.
Publicado: (2019)

Complement Inhibition in ANCA-Associated Vasculitis
por: Tesar, Vladimir, et al.
Publicado: (2022)

The involvement of NETs in ANCA-associated vasculitis
por: Shiratori-Aso, Satoka, et al.
Publicado: (2023)

Neutrophil Extracellular Traps in ANCA-Associated Vasculitis
por: Söderberg, Daniel, et al.
Publicado: (2016)

Genetic Susceptibility to ANCA-Associated Vasculitis: State of the Art
por: Bonatti, Francesco, et al.
Publicado: (2014)

Environmental factors influencing the risk of ANCA-associated vasculitis
por: Zhao, Wen-Man, et al.
Publicado: (2022)

New Insights Into Novel Therapeutic Targets in ANCA-Associated Vasculitis
por: Nozaki, Yuji
Publicado: (2021)

Unmet needs in ANCA-associated vasculitis: Physicians’ and patients’ perspectives
por: Quartuccio, Luca, et al.
Publicado: (2023)

The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
por: Takeda, Sayo, et al.
Publicado: (2019)

The Complement System and ANCA Associated Vasculitis in the Era of Anti-Complement Drugs
por: Kimoto, Yasutaka, et al.
Publicado: (2022)

Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA rise
por: Wojcik, Iwona, et al.
Publicado: (2023)

Extracellular neutrophil traps: a novel therapeutic target in ANCA-associated vasculitis?
por: Diamantopoulos, Andreas P.
Publicado: (2013)

ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020)

Dysregulated Responsiveness of Circulating Dendritic Cells to Toll-Like Receptors in ANCA-Associated Vasculitis
por: Braudeau, Cécile, et al.
Publicado: (2017)

The Co-inhibitor BTLA Is Functional in ANCA-Associated Vasculitis and Suppresses Th17 Cells
por: Werner, Kai, et al.
Publicado: (2019)

ANCA-Associated Vasculitis: An Update
por: Almaani, Salem, et al.
Publicado: (2021)

Immunopathogenesis of ANCA-Associated Vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

Comorbidities in ANCA-associated vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

The immunopathology of ANCA-associated vasculitis
por: McKinney, Eoin F., et al.
Publicado: (2014)

ANCA-associated vasculitis of the appendix
por: Leaver, Phillip J, et al.
Publicado: (2019)

Subcutaneous Immunoglobulin for Antibody Deficiency in Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis
por: Kant, Sam, et al.
Publicado: (2019)

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis
por: Thompson, Gwen E., et al.
Publicado: (2020)

Low Density Granulocytes in ANCA Vasculitis Are Heterogenous and Hypo-Responsive to Anti-Myeloperoxidase Antibodies
por: Ui Mhaonaigh, Aisling, et al.
Publicado: (2019)

Adult-Onset ANCA-Associated Vasculitis in SAVI: Extension of the Phenotypic Spectrum, Case Report and Review of the Literature
por: Staels, Frederik, et al.
Publicado: (2020)

A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis
por: Arnold, Jack, et al.
Publicado: (2022)

CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1
por: Zeisbrich, Markus, et al.
Publicado: (2021)

The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus
por: Banos, Aggelos, et al.
Publicado: (2023)

Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA – associated vasculitis
por: Satrapova, Veronika, et al.
Publicado: (2023)

Progress in treatment of ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2012)

Mechanisms of thrombosis in ANCA-associated vasculitis
por: Misra, Durga Prasanna, et al.
Publicado: (2021)

Granulomatous Inflammation in ANCA-Associated Vasculitis
por: Müller, Antje, et al.
Publicado: (2021)

Emerging Cellular Therapies for Anti-myeloperoxidase Vasculitis and Other Autoimmune Diseases
por: Odobasic, Dragana, et al.
Publicado: (2021)

The C3aR promotes macrophage infiltration and regulates ANCA production but does not affect glomerular injury in experimental anti-myeloperoxidase glomerulonephritis
por: Dick, Jonathan, et al.
Publicado: (2018)

Vitamin D status in ANCA-associated vasculitis
por: Doubelt, Irena, et al.
Publicado: (2023)

ANCA Associated Vasculitis Subtypes: Response [Letter]
por: Merkel, Peter A, et al.
Publicado: (2022)

ANCA Associated Vasculitis Subtypes: Response [Response to Letter]
por: Austin, Keziah, et al.
Publicado: (2022)

ANCA-associated vasculitis in childhood: recent advances
por: Calatroni, Marta, et al.
Publicado: (2017)

CX3CL1-induced CD16(+) monocytes extravasation in myeloperoxidase-ANCA-associated vasculitis correlates with renal damage
por: Tang, Jiale, et al.
Publicado: (2022)

FIBROTIC PROTEASE 3 ANCA-ASSOCIATED VASCULITIS
por: Megri, Mohammed, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vlfarthno3frgef1d0umvjstur